Thomas Joseph Dee
Corporate Officer/Principal at Abbott Laboratories Trading (Shanghai) Co. Ltd.
Thomas Joseph Dee active positions
| Companies | Position | Start | End |
|---|---|---|---|
Abbott Laboratories Trading (Shanghai) Co. Ltd.
 Abbott Laboratories Trading (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Trading (Shanghai) Co., Ltd. is a subsidiary of Abbott Laboratories SA. It primarily offers medicines. The company is headquartered in Shanghai, China. | Corporate Officer/Principal | 21/09/2011 | - |
Career history of Thomas Joseph Dee
Former positions of Thomas Joseph Dee
| Companies | Position | Start | End |
|---|---|---|---|
| AVEXIS INC | Director of Finance/CFO | 31/07/2015 | 18/10/2017 |
| ABBOTT INDIA LIMITED | Director/Board Member | 08/04/2008 | 29/09/2013 |
| Independent Dir/Board Member | 21/09/2011 | 25/04/2013 | |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 31/12/1989 | 31/03/2011 |
| Corporate Officer/Principal | 31/03/2011 | 31/08/2013 |
Training of Thomas Joseph Dee
| Northern Illinois University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistics
International
| United States | 5 |
| India | 2 |
| China | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBOTT INDIA LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Abbott Laboratories Trading (Shanghai) Co. Ltd.
Abbott Laboratories Trading (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Trading (Shanghai) Co., Ltd. is a subsidiary of Abbott Laboratories SA. It primarily offers medicines. The company is headquartered in Shanghai, China. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Thomas Joseph Dee
- Experience
